515 related articles for article (PubMed ID: 7563169)
1. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer.
Sedláková I; Laco J; Caltová K; Červinka M; Tošner J; Řezáč A; Špaček J
Int J Gynecol Cancer; 2015 Feb; 25(2):236-43. PubMed ID: 25594141
[TBL] [Abstract][Full Text] [Related]
3. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.
Beck J; Bohnet B; Brügger D; Bader P; Dietl J; Scheper RJ; Kandolf R; Liu C; Niethammer D; Gekeler V
Br J Cancer; 1998; 77(1):87-91. PubMed ID: 9459150
[TBL] [Abstract][Full Text] [Related]
4. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
Arts HJ; Katsaros D; de Vries EG; Massobrio M; Genta F; Danese S; Arisio R; Scheper RJ; Kool M; Scheffer GL; Willemse PH; van der Zee AG; Suurmeijer AJ
Clin Cancer Res; 1999 Oct; 5(10):2798-805. PubMed ID: 10537344
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma.
Lu D; Shi HC; Wang ZX; Gu XW; Zeng YJ
Br J Biomed Sci; 2011; 68(2):69-74. PubMed ID: 21706917
[TBL] [Abstract][Full Text] [Related]
6. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42.
Moran E; Cleary I; Larkin AM; Amhlaoibh RN; Masterson A; Scheper RJ; Izquierdo MA; Center M; O'Sullivan F; Clynes M
Eur J Cancer; 1997 Apr; 33(4):652-60. PubMed ID: 9274450
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of multidrug resistance involve proteins: a flow cytometric analysis.
Boutonnat J; Bonnefoix T; Mousseau M; Seigneurin D; Ronot X
Anticancer Res; 1998; 18(4C):2993-9. PubMed ID: 9713498
[TBL] [Abstract][Full Text] [Related]
9. [Proteins of resistance and drug resistance in ovarian carcinoma patients].
Sedláková I; Laco J; Tošner J; Caltová K; Cervinka M; Rezáč A; Spaček J; Skapinec P
Klin Onkol; 2012; 25(6):457-63. PubMed ID: 23301649
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.
Michieli M; Damiani D; Ermacora A; Masolini P; Raspadori D; Visani G; Scheper RJ; Baccarani M
Br J Haematol; 1999 Feb; 104(2):328-35. PubMed ID: 10050716
[TBL] [Abstract][Full Text] [Related]
11. Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs.
Izquierdo MA; Scheffer GL; Flens MJ; Shoemaker RH; Rome LH; Scheper RJ
Cytotechnology; 1996; 19(3):191-7. PubMed ID: 8862006
[TBL] [Abstract][Full Text] [Related]
12. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival.
Borg AG; Burgess R; Green LM; Scheper RJ; Yin JA
Br J Haematol; 1998 Dec; 103(4):1083-91. PubMed ID: 9886324
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells.
Michieli M; Damiani D; Ermacora A; Raspadori D; Michelutti A; Grimaz S; Fanin R; Russo D; Lauria F; Masolini P; Baccarani M
Br J Haematol; 1997 Feb; 96(2):356-65. PubMed ID: 9029025
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
Stein U; Walther W; Laurencot CM; Scheffer GL; Scheper RJ; Shoemaker RH
J Natl Cancer Inst; 1997 Jun; 89(11):807-13. PubMed ID: 9182980
[TBL] [Abstract][Full Text] [Related]
16. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
17. Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours.
Zurita AJ; Diestra JE; Condom E; García Del Muro X; Scheffer GL; Scheper RJ; Pérez J; Germà-Lluch JR; Izquierdo MA
Br J Cancer; 2003 Mar; 88(6):879-86. PubMed ID: 12644825
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of chemoresistance markers in women with epithelial ovarian carcinoma.
Goff BA; Paley PJ; Greer BE; Gown AM
Gynecol Oncol; 2001 Apr; 81(1):18-24. PubMed ID: 11277644
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia.
Michieli M; Damiani D; Ermacora A; Geromin A; Michelutti A; Masolini P; Baccarani M
Br J Haematol; 2000 Mar; 108(4):703-9. PubMed ID: 10792272
[TBL] [Abstract][Full Text] [Related]
20. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ
Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
